Andreas Orfanos, MBBCh, FFPM
Chief Operating Officer
Dr. Andreas Orfanos serves as the Company’s Chief Operating Officer since April 2022.
Dr. Orfanos received his FFPM from the Royal College of Physicians of the United Kingdom and his MBBCh and MBA from the University of the Witwatersrand, South Africa.
Dr. Orfanos has over 30 years of extensive international experience in strategy development, executive and operational management roles in major healthcare sectors, with a particular focus on global pharmaceuticals and biotechnology. Prior to joining Bellus, Dr. Orfanos was the Director of the MHICC, and the CEO of Innovacor. Dr. Orfanos was formerly Vice President at Thrasos Therapeutics, Executive Vice President, Strategic Planning and Scientific Affairs at Neurochem. He also served at Picchio Pharma, Novartis Pharmaceuticals, Sandoz and Lifecare. He also established ORFANOS Global Healthcare Consulting Inc., which focused on creating value for organizations through strategy development and the advancement of medical products and technologies. He has held various lead roles in strategy development, business development, leadership of specialty business units, and in drug development and clinical management. He has been instrumental in several leading studies in the fields of transplantation/immunology, oncology, renal, infectious, and cardiovascular diseases.